Retatrutide 10 mg
- Batch
RT10-2609A- Net content
- 9.47 mg
- Identity (HPLC)
- Confirmed
- Endotoxins
- Pass
- Lab
- Vanguard Laboratory
- Reported
- 16 Oct 2026
- Report number
V261007-11 001
Prime Peptides supplies research peptides exclusively for qualified laboratory research. Please confirm the following before continuing.Prime Peptides จำหน่ายเปปไทด์สำหรับการวิจัยในห้องปฏิบัติการที่มีคุณสมบัติเท่านั้น กรุณายืนยันข้อมูลต่อไปนี้ก่อนดำเนินการต่อ
By continuing, you confirm that the statements above are true. Our products are not intended for human or veterinary use, are not for diagnostic procedures, and have not been evaluated or registered by the Thai Food and Drug Administration.การดำเนินการต่อถือว่าท่านยืนยันว่าข้อความข้างต้นเป็นความจริง ผลิตภัณฑ์ของเราไม่ได้มีไว้สำหรับใช้กับมนุษย์หรือสัตว์ ไม่ได้มีไว้สำหรับการวินิจฉัย และไม่ได้รับการประเมินหรือขึ้นทะเบียนจากสำนักงานคณะกรรมการอาหารและยา (อย.)
Full disclaimerข้อจำกัดความรับผิดฉบับเต็ม.
Not a researcher?ไม่ใช่นักวิจัย? Leaveออก

Every batch is tested by an independent lab before it goes on sale. Match the batch number on your vial to its report.
RT10-2609AV261007-11 001Tested by Vanguard LaboratoryDownload PDF
See all testsRT20-2609AV261007-11 002Tested by Vanguard LaboratoryDownload PDF
See all testsEvery Retatrutide test · 2 tests, newest first
Retatrutide is a synthetic peptide studied as a triple-receptor (GIP / GLP-1 / glucagon) agonist in metabolic research.
For laboratory research use onlyRetatrutide is studied as a triple-receptor agonist across GIP, GLP-1 and glucagon signaling. This page describes the research literature; it does not provide clinical or medical guidance.
Studied in models of insulin secretion and satiety signaling.
Studied in models of insulin sensitivity and lipid handling.
Studied in models of energy expenditure and lipolysis.
Studied for how the three receptor signals interact.
Peer-reviewed publications for further reading.
References are provided for research context only. Product information is not medical advice and is not a recommendation for human or veterinary use.
Research context, batch testing, storage and verification for Retatrutide.
Retatrutide, also identified by the developmental code LY3437943, is a synthetic peptide investigated in published research as an agonist at the GIP, GLP-1 and glucagon receptors. Prime Peptides supplies it as a lyophilized material strictly for in-vitro laboratory research.
Reference databases report a molecular weight of approximately 4,731 g/mol for Retatrutide. The Prime Peptides reference profile records 4,731.3 g/mol. This information is provided for compound identification and laboratory reference only.
Published receptor pharmacology describes semaglutide as a GLP-1 receptor agonist, tirzepatide as a dual GIP and GLP-1 receptor agonist, and Retatrutide as a triple GIP, GLP-1 and glucagon receptor agonist. This is a comparison of receptor profiles reported in the research literature, not a claim of clinical equivalence or suitability.
Every batch goes through three layers of quality control. Our manufacturer runs its own QC and has its production independently tested by Janoshik Analytical. Then Vanguard or Janoshik tests every batch we stock again, for identity, HPLC purity, net content and endotoxins before we approve it for sale.
Every approved batch has its lab report on the Test Results page.
We target 99%+ purity by HPLC. The actual purity of each batch is measured independently and published in its lab report, so you can check the result yourself.
Follow the product label and batch documentation. Current product guidance is to store the sealed lyophilized vial at −20°C, protected from light, and to avoid repeated freeze-thaw cycles. Prime Peptides release testing verifies the batch against its release criteria; it does not independently establish product shelf life.
Peer-reviewed research is indexed on PubMed under both “Retatrutide” and “LY3437943.” The Selected Literature section on this page links to the discovery work by Coskun et al. and published studies by Jastreboff et al., Rosenstock et al. and Sanyal et al.
Each vial carries a batch number linked to its matching lab report (COA). Scan the QR code on the vial or search the batch number on Test Results to see that batch’s record and the original lab documents.
ACCOUNT
Track your orders and reorder in a few taps. You can also check out as a guest.
or continue with email
Why create an account?
New here?
Already have an account?
Welcome to Prime Peptides
Join our list for restock alerts and new lab reports. We email your code right away.
First order of ฿1,000 or more, within 14 days. Unsubscribe any time. See our Privacy Policy.
You are on the list
WELCOME10
Enter it at checkout within 14 days. It stacks with the multi-vial discount. We also sent it to your inbox.
Shop peptidesFirst order of ฿1,000 or more. Valid 14 days. One use per customer.
You are on the list
The welcome discount is for first orders, so it doesn’t apply to this email address. We’ll email you about new batches, lab reports and restocks.
Shop peptides